Universities and colleges built budgets around federal largess. The Trump administration is forcing them to take a fiscal haircut on indirect costs.
National Institutes of Health slashed overhead costs allowed under its grants to match private foundations, but the two don't ...
Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...
The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.
After weeks of disruption to scientific federal grants, the National Institutes of Health has fallen behind in funding ...
UNC Charlotte received the most NIH funding in the area — $56 million since the 2015 fiscal year. The university received ...
The state's life sciences industry, which generated $3.3 billion in economic activity in 2023, could be severely impacted by ...
This is seismic,” said Dr. Colin Duckett, vice dean for basic and preclinical science at the Duke University School of ...
Private investment in pharmaceutical research can't replace the NIH. Both public investment and the private sector are needed ...
Changes to a key funding formula will reduce research grants at hospitals and universities by billions — and may discourage ...
The National Institutes of Health proposal would limit indirect costs for research projects to 15 percent of grants.
Additionally, we identified several genes that, when targeted, may be suitable for drug repurposing for both subtypes of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results